Randomized Multicenter Phase II Trial of Two Different Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer Purpose: The median survival time for women with ...

High doses of vitamin C could be a new breakthrough in treating cancer. The University of Iowa Health Care Carver College of Medicine has shared results from a randomized, phase 2 trial testing the ...

The odds of cisplatin-induced acute kidney injury decreased with prophylactic administration of intravenous magnesium. Infusing prophylactic magnesium before initiating intravenous cisplatin for ...

Screening for Depressed Mood in Patients With Cancer Using the MD Anderson Symptom Inventory: Investigation of a Practical Approach for the Oncologist We conducted a retrospective review of the ...

Patients with cancer who received prophylactic intravenous (IV) magnesium before starting cisplatin had a lower risk for cisplatin-associated acute kidney injury (AKI) than those who did not receive ...

The author faced challenges with chemotherapy, initially opting for a combination of oral and intravenous treatments before switching to oral medication only. The COVID-19 pandemic allowed the author ...

Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with ...

A home-infusion model combining remote physiologic monitoring, virtual command center supervision, and in-home nursing enabled delivery of 93 IV chemotherapy infusions without infusion reactions or ...

Subcutaneous administration of the anti-PD-1 monoclonal antibody toripalimab achieves similar drug exposure as the intravenous formulation in advanced non-squamous non-small cell lung cancer (NSCLC), ...